The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS

W. H. Herman; S. L. Edelstein; R. E. Ratner; M. G. Montez; R. T. Ackermann; T. J. Orchard; M. A. Foulkes; P. Zhang; C. D. Saudek; M. B. Brown

doi:10.1089/dia.2013.1511

The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS

W. H. Herman, S. L. Edelstein, R. E. Ratner, M. G. Montez, R. T. Ackermann, T. J. Orchard, M. A. Foulkes, P. Zhang, C. D. Saudek, M. B. Brown

Medicine, General Medicine Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Journal	Diabetes Technology and Therapeutics
Volume	15
Issue number	SUPPL.1
DOIs	https://doi.org/10.1089/dia.2013.1511
State	Published - Jun 1 2013

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/dia.2013.1511

Cite this

Herman, W. H., Edelstein, S. L., Ratner, R. E., Montez, M. G., Ackermann, R. T., Orchard, T. J., Foulkes, M. A., Zhang, P., Saudek, C. D., & Brown, M. B. (2013). The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS. Diabetes Technology and Therapeutics, 15(SUPPL.1). https://doi.org/10.1089/dia.2013.1511

Herman, W. H. ; Edelstein, S. L. ; Ratner, R. E. ; Montez, M. G. ; Ackermann, R. T. ; Orchard, T. J. ; Foulkes, M. A. ; Zhang, P. ; Saudek, C. D. ; Brown, M. B. / The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention : An intent-to-treat analysis of the DPP/DPPOS. In: Diabetes Technology and Therapeutics. 2013 ; Vol. 15, No. SUPPL.1.

@article{b7a611bbacfa4166bbc556ce5e016279,

title = "The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS",

author = "Herman, {W. H.} and Edelstein, {S. L.} and Ratner, {R. E.} and Montez, {M. G.} and Ackermann, {R. T.} and Orchard, {T. J.} and Foulkes, {M. A.} and P. Zhang and Saudek, {C. D.} and Brown, {M. B.}",

year = "2013",

month = jun,

day = "1",

doi = "10.1089/dia.2013.1511",

language = "English (US)",

volume = "15",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "SUPPL.1",

}

Herman, WH, Edelstein, SL, Ratner, RE, Montez, MG, Ackermann, RT, Orchard, TJ, Foulkes, MA, Zhang, P, Saudek, CD & Brown, MB 2013, 'The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS', Diabetes Technology and Therapeutics, vol. 15, no. SUPPL.1. https://doi.org/10.1089/dia.2013.1511

The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention : An intent-to-treat analysis of the DPP/DPPOS. / Herman, W. H.; Edelstein, S. L.; Ratner, R. E.; Montez, M. G.; Ackermann, R. T.; Orchard, T. J.; Foulkes, M. A.; Zhang, P.; Saudek, C. D.; Brown, M. B.

In: Diabetes Technology and Therapeutics, Vol. 15, No. SUPPL.1, 01.06.2013.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention

T2 - An intent-to-treat analysis of the DPP/DPPOS

AU - Herman, W. H.

AU - Edelstein, S. L.

AU - Ratner, R. E.

AU - Montez, M. G.

AU - Ackermann, R. T.

AU - Orchard, T. J.

AU - Foulkes, M. A.

AU - Zhang, P.

AU - Saudek, C. D.

AU - Brown, M. B.

PY - 2013/6/1

Y1 - 2013/6/1

UR - http://www.scopus.com/inward/record.url?scp=84896805256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896805256&partnerID=8YFLogxK

U2 - 10.1089/dia.2013.1511

DO - 10.1089/dia.2013.1511

M3 - Comment/debate

C2 - 23441713

AN - SCOPUS:84896805256

VL - 15

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - SUPPL.1

ER -

The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this